Quantum BioPharma Ltd. (QNTM) — Financial Flexibility Index
Quantum BioPharma Ltd. (QNTM) has a Financial Flexibility Index of -0.10x as of March 2026. Free cash flow of $-1.65 Million (operating CF $-1.65 Million minus capex $3.00) represents 0% of total liabilities ($16.40 Million). Check Quantum BioPharma Ltd. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Quantum BioPharma Ltd. Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Quantum BioPharma Ltd. across 11 annual periods. For the full cash flow conversion analysis, see Quantum BioPharma Ltd. cash flow conversion.
Annual Financial Flexibility Index for Quantum BioPharma Ltd. (2015–2025)
Year-by-year free cash flow to debt coverage for Quantum BioPharma Ltd.. Explore how well can Quantum BioPharma Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.39x | $-8.38 Million | $-8.38 Million | $6.05 Million | ▼ -34.6% |
| 2024 | -1.03x | $-6.88 Million | $-6.88 Million | $6.68 Million | ▲ +56.6% |
| 2023 | -2.37x | $-10.83 Million | $-10.83 Million | $4.57 Million | ▲ +33.3% |
| 2022 | -3.55x | $-27.97 Million | $-28.33 Million | $7.87 Million | ▼ -55.1% |
| 2021 | -2.29x | $-20.25 Million | $-20.75 Million | $8.83 Million | ▲ +32.2% |
| 2020 | -3.38x | $-19.13 Million | $-19.13 Million | $5.66 Million | ▼ -74.8% |
| 2019 | -1.93x | $-13.42 Million | $-13.71 Million | $6.94 Million | ▲ +76.7% |
| 2018 | -8.29x | $-10.61 Million | $-13.58 Million | $1.28 Million | ▼ -239.9% |
| 2017 | 5.93x | $5.97 Million | $-119.18K | $1.01 Million | ▲ +1436.8% |
| 2016 | -0.44x | $-27.24K | $-27.24K | $61.43K | ▼ -42203.3% |
| 2015 | 0.00x | $-63.44 | $-63.44 | $60.53K | — |